Rasmus Rørth

3.7k total citations · 1 hit paper
63 papers, 2.4k citations indexed

About

Rasmus Rørth is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Rasmus Rørth has authored 63 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Cardiology and Cardiovascular Medicine, 18 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Surgery. Recurrent topics in Rasmus Rørth's work include Heart Failure Treatment and Management (25 papers), Cardiovascular Function and Risk Factors (23 papers) and Diabetes Treatment and Management (12 papers). Rasmus Rørth is often cited by papers focused on Heart Failure Treatment and Management (25 papers), Cardiovascular Function and Risk Factors (23 papers) and Diabetes Treatment and Management (12 papers). Rasmus Rørth collaborates with scholars based in Denmark, United Kingdom and United States. Rasmus Rørth's co-authors include Lars Køber, Søren Lund Kristensen, John J.V. McMurray, Pardeep S. Jhund, Mark C. Petrie, Kieran F. Docherty, David Preiss, Naveed Sattar, Emil Loldrup Fosbøl and Michael R. Zile and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Rasmus Rørth

60 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

2019 1.1k citations Søren Lund Kristensen, Rasmus Rørth et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rasmus Rørth Denmark	20	1.1k	1.1k	542	504	225	63	2.4k
Mervete Miftaraj Sweden	20	1.9k 1.6×	869 0.8×	420 0.8×	660 1.3×	328 1.5×	49	2.8k
Ann–Marie Svensson Sweden	14	2.0k 1.7×	1.0k 0.9×	408 0.8×	591 1.2×	345 1.5×	21	3.0k
Ruth L. Coleman United Kingdom	19	1.1k 1.0×	625 0.6×	249 0.5×	392 0.8×	260 1.2×	60	1.9k
Kieran F. Docherty United Kingdom	24	1.9k 1.7×	1.6k 1.4×	672 1.2×	825 1.6×	196 0.9×	113	3.4k
Brian Claggett United States	16	1.8k 1.5×	1.6k 1.4×	931 1.7×	738 1.5×	243 1.1×	32	3.4k
Katarina Eeg‐Olofsson Sweden	29	1.8k 1.5×	581 0.5×	349 0.6×	652 1.3×	302 1.3×	85	2.5k
Linda Mellbin Sweden	22	1.1k 1.0×	655 0.6×	412 0.8×	283 0.6×	208 0.9×	96	1.9k
Jan Cederholm Sweden	31	1.9k 1.7×	738 0.7×	516 1.0×	450 0.9×	378 1.7×	76	2.9k
Lars Johansson Sweden	17	647 0.6×	427 0.4×	371 0.7×	353 0.7×	193 0.9×	43	1.3k
George Sokos United States	15	1.2k 1.1×	1.6k 1.4×	542 1.0×	979 1.9×	205 0.9×	59	3.1k

Countries citing papers authored by Rasmus Rørth

Since Specialization

Citations

This map shows the geographic impact of Rasmus Rørth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rasmus Rørth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rasmus Rørth more than expected).

Fields of papers citing papers by Rasmus Rørth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rasmus Rørth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rasmus Rørth. The network helps show where Rasmus Rørth may publish in the future.

Co-authorship network of co-authors of Rasmus Rørth

This figure shows the co-authorship network connecting the top 25 collaborators of Rasmus Rørth. A scholar is included among the top collaborators of Rasmus Rørth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rasmus Rørth. Rasmus Rørth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kousgaard, Marius Brostrøm, et al.. (2025). Patients’ experiences with GLP1-RAs – a systematic review. Scandinavian Journal of Primary Health Care. 43(2). 370–379.

Thune, Jens Jakob, Jens Cosedis Nielsen, Jens Haarbo, et al.. (2023). Diabetes and Implantable Cardioverter Defibrillator in Nonischemic Systolic Heart Failure: An Extended Follow-Up Analysis of DANISH. Circulation Heart Failure. 16(10). e010606–e010606.

Petersen, Jeppe Kofoed, Emil Loldrup Fosbøl, Rasmus Rørth, et al.. (2023). Employment status at time of acute myocardial infarction and risk of death and recurrent acute myocardial infarction. European Journal of Preventive Cardiology. 30(7). 572–580.

Butt, Jawad H., Mikkel Porsborg Andersen, Maurizio Sessa, et al.. (2023). Trends in Medical and Device Therapies Following Incident Heart Failure in Denmark during 1996–2019: A Nationwide Register-Based Follow-Up Study. Journal of Cardiovascular Development and Disease. 10(9). 362–362. 3 indexed citations

Bundgaard, Johan Skov, Ulrik M. Mogensen, Stefan Christensen, et al.. (2022). Healthcare cost variation in patients with heart failure: a nationwide study. Public Health. 207. 88–93. 2 indexed citations

Ersbøll, Mads, Naja Emborg Vinding, Jawad H. Butt, et al.. (2022). Incidence of thyroid dysfunction following initiation of amiodarone treatment in patients with and without heart failure: a nationwide cohort study. EP Europace. 25(2). 291–299. 9 indexed citations

Bundgaard, Johan Skov, Ulrik M. Mogensen, Stefan Christensen, et al.. (2022). Direct and indirect costs of heart failure in relation to diabetes status - A nationwide study. Nutrition Metabolism and Cardiovascular Diseases. 32(8). 1880–1885. 3 indexed citations

Vinding, Naja Emborg, Søren Lund Kristensen, Rasmus Rørth, et al.. (2022). Ischemic Stroke Severity and Mortality in Patients With and Without Atrial Fibrillation. Journal of the American Heart Association. 11(4). e022638–e022638. 40 indexed citations

Rørth, Rasmus, Jawad H. Butt, Morten Schmidt, et al.. (2022). Return to work after acute myocardial infarction with cardiogenic shock: a Danish nationwide cohort study. European Heart Journal Acute Cardiovascular Care. 11(5). 397–406. 6 indexed citations

10.

Butt, Jawad H., Kristian Kragholm, Christina Kruuse, et al.. (2021). Workforce Attachment after Ischemic Stroke – The Importance of Time to Thrombolytic Therapy. Journal of Stroke and Cerebrovascular Diseases. 30(11). 106031–106031. 2 indexed citations

11.

Rørth, Rasmus, Christian Torp‐Pedersen, Peter Weeke, et al.. (2021). Incidence of heart valve disease in women treated with the ergot-derived dopamine agonist bromocriptine. BMC Cardiovascular Disorders. 21(1). 622–622. 2 indexed citations

12.

Rørth, Rasmus, Jawad H. Butt, Søren Lund Kristensen, et al.. (2020). Five-year risk of heart failure and death following myocardial infarction with cardiogenic shock: a nationwide cohort study. European Heart Journal Acute Cardiovascular Care. 10(1). 40–49. 8 indexed citations

13.

Christiansen, M., Ulrik M. Mogensen, Johan Skov Bundgaard, et al.. (2020). Add-on therapy in metformin-treated patients with type 2 diabetes at moderate cardiovascular risk: a nationwide study. Cardiovascular Diabetology. 19(1). 107–107. 27 indexed citations

14.

Rørth, Rasmus, Lene Holmvang, Christian Torp‐Pedersen, et al.. (2019). Antithrombotic treatment and major adverse cardiac events after bleeding in patients with myocardial infarction: a retrospective analysis of nationwide registry data. European Heart Journal - Cardiovascular Pharmacotherapy. 6(1). 14–21. 5 indexed citations

15.

Shen, Li, Rasmus Rørth, Deborah Cosmi, et al.. (2019). Insulin Treatment and Clinical Outcomes in Patients with Diabetes and Heart Failure with Preserved Ejection Fraction. European Journal of Heart Failure. 21(8). 974–984. 50 indexed citations

16.

Fosbøl, Emil Loldrup, Rasmus Rørth, Morten Schou, et al.. (2019). Association of Carpal Tunnel Syndrome With Amyloidosis, Heart Failure, and Adverse Cardiovascular Outcomes. Journal of the American College of Cardiology. 74(1). 15–23. 79 indexed citations

17.

Oellgaard, Jens, Peter Gæde, Peter Rossing, et al.. (2018). Reduced risk of heart failure with intensified multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: 21 years of follow-up in the randomised Steno-2 study. Diabetologia. 61(8). 1724–1733. 59 indexed citations

18.

Rørth, Rasmus, Pardeep S. Jhund, Søren Lund Kristensen, et al.. (2018). The Prognostic Value of Troponin T and N-terminal pro B-type Natriuretic Peptide, Alone and in Combination, in Heart Failure Patients with and without Diabetes. European Journal of Heart Failure. 21(1). 40–49. 47 indexed citations

19.

Zareini, Bochra, Rasmus Rørth, Anders Holt, et al.. (2018). POOR PROGNOSIS FOLLOWING DIABETES MELLITUS IN PATIENTS WITH HEART FAILURE: A NATIONWIDE COHORT STUDY. Journal of the American College of Cardiology. 71(11). A675–A675. 1 indexed citations

20.

Rørth, Rasmus, Dan Eik Høfsten, Kasper Iversen, et al.. (2017). MIDREGIONAL PROADRENOMEDULLIN: A PROGNOSTIC MARKER OF MORTALITY AND HEART FAILURE IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION. Journal of the American College of Cardiology. 69(11). 11–11. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact